319 related articles for article (PubMed ID: 9294150)
1. A study of the interferon antiviral mechanism: apoptosis activation by the 2-5A system.
Castelli JC; Hassel BA; Wood KA; Li XL; Amemiya K; Dalakas MC; Torrence PF; Youle RJ
J Exp Med; 1997 Sep; 186(6):967-72. PubMed ID: 9294150
[TBL] [Abstract][Full Text] [Related]
2. The 2-5A system in viral infection and apoptosis.
Castelli J; Wood KA; Youle RJ
Biomed Pharmacother; 1998; 52(9):386-90. PubMed ID: 9856285
[TBL] [Abstract][Full Text] [Related]
3. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis.
Castelli JC; Hassel BA; Maran A; Paranjape J; Hewitt JA; Li XL; Hsu YT; Silverman RH; Youle RJ
Cell Death Differ; 1998 Apr; 5(4):313-20. PubMed ID: 10200477
[TBL] [Abstract][Full Text] [Related]
4. The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.
Player MR; Torrence PF
Pharmacol Ther; 1998 May; 78(2):55-113. PubMed ID: 9623881
[TBL] [Abstract][Full Text] [Related]
5. Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity.
Asthana A; Gaughan C; Dong B; Weiss SR; Silverman RH
mBio; 2021 Aug; 12(4):e0178121. PubMed ID: 34372695
[TBL] [Abstract][Full Text] [Related]
6. A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L.
Malathi K; Paranjape JM; Bulanova E; Shim M; Guenther-Johnson JM; Faber PW; Eling TE; Williams BR; Silverman RH
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14533-8. PubMed ID: 16203993
[TBL] [Abstract][Full Text] [Related]
7. Chemistry and biochemistry of 2',5'-oligoadenylate-based antisense strategy.
Adah SA; Bayly SF; Cramer H; Silverman RH; Torrence PF
Curr Med Chem; 2001 Aug; 8(10):1189-212. PubMed ID: 11472236
[TBL] [Abstract][Full Text] [Related]
8. Dissection of the roles of adenine ring nitrogen (N-1) and exocyclic amino (N-6) moieties in the interaction of 2-5A with RNase L.
Player MR; Kalinichenko EN; Podkopaeva TL; Mikhailopulo IA; Seela F; Torrence PF
Biochem Biophys Res Commun; 1998 Apr; 245(2):430-4. PubMed ID: 9571169
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 2',5'-oligo(A)-dependent endoribonuclease by 2',5'-oligo(A) degradation products.
Williams GJ; De Benedetti A; Baglioni C
Virology; 1986 Jun; 151(2):233-42. PubMed ID: 2422811
[TBL] [Abstract][Full Text] [Related]
10. A convenient and sensitive fluorescence resonance energy transfer assay for RNase L and 2',5' oligoadenylates.
Thakur CS; Xu Z; Wang Z; Novince Z; Silverman RH
Methods Mol Med; 2005; 116():103-13. PubMed ID: 16000857
[TBL] [Abstract][Full Text] [Related]
11. RNase L plays a role in the antiviral response to West Nile virus.
Scherbik SV; Paranjape JM; Stockman BM; Silverman RH; Brinton MA
J Virol; 2006 Mar; 80(6):2987-99. PubMed ID: 16501108
[TBL] [Abstract][Full Text] [Related]
12. 2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication.
Rice AP; Roberts WK; Kerr IM
J Virol; 1984 Apr; 50(1):220-8. PubMed ID: 6422053
[TBL] [Abstract][Full Text] [Related]
13. Initiation of a ZAKα-dependent ribotoxic stress response by the innate immunity endoribonuclease RNase L.
Xi J; Snieckute G; Martínez JF; Arendrup FSW; Asthana A; Gaughan C; Lund AH; Bekker-Jensen S; Silverman RH
Cell Rep; 2024 Apr; 43(4):113998. PubMed ID: 38551960
[TBL] [Abstract][Full Text] [Related]
14. Small self-RNA generated by RNase L amplifies antiviral innate immunity.
Malathi K; Dong B; Gale M; Silverman RH
Nature; 2007 Aug; 448(7155):816-9. PubMed ID: 17653195
[TBL] [Abstract][Full Text] [Related]
15. Impact of RNase L overexpression on viral and cellular growth and death.
Zhou A; Paranjape JM; Hassel BA; Nie H; Shah S; Galinski B; Silverman RH
J Interferon Cytokine Res; 1998 Nov; 18(11):953-61. PubMed ID: 9858317
[TBL] [Abstract][Full Text] [Related]
16. RNase L dimerization in a mammalian two-hybrid system in response to 2',5'-oligoadenylates.
Naik S; Paranjape JM; Silverman RH
Nucleic Acids Res; 1998 Mar; 26(6):1522-7. PubMed ID: 9490801
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of a RNAse L inhibitor. A new component of the interferon-regulated 2-5A pathway.
Bisbal C; Martinand C; Silhol M; Lebleu B; Salehzada T
J Biol Chem; 1995 Jun; 270(22):13308-17. PubMed ID: 7539425
[TBL] [Abstract][Full Text] [Related]
18. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase.
Li G; Xiang Y; Sabapathy K; Silverman RH
J Biol Chem; 2004 Jan; 279(2):1123-31. PubMed ID: 14570908
[TBL] [Abstract][Full Text] [Related]
19. A viral RNA competitively inhibits the antiviral endoribonuclease domain of RNase L.
Townsend HL; Jha BK; Han JQ; Maluf NK; Silverman RH; Barton DJ
RNA; 2008 Jun; 14(6):1026-36. PubMed ID: 18426919
[TBL] [Abstract][Full Text] [Related]
20. 2-5A induces a conformational change in the ankyrin-repeat domain of RNase L.
Nakanishi M; Goto Y; Kitade Y
Proteins; 2005 Jul; 60(1):131-8. PubMed ID: 15849753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
